Carlyle and SK Capital Partners announce expiration of bluebird bio tender offer

Carlyle and SK Capital Partners announce expiration of bluebird bio tender offer

Carlyle and SK Capital Partners have announced the expiration of their tender offer to acquire all outstanding common stock of bluebird bio, Inc. The offer, which commenced on March 7, 2025, expired as scheduled at one minute after 11:59 p.m. New York City time on May 29, 2025.Equiniti Trust Company, LLC advised that a total of 5,868,196 shares were validly tendered and not withdrawn by the expiration time. This represents approximately 59.8% of…